Impact of removing mucosal barrier injury laboratory-confirmed bloodstream infections from central line-associated bloodstream infection rates in the National Healthcare Safety Network, 2014.

See, Isaac; Soe, Minn M; Epstein, Lauren; Edwards, Jonathan R; Magill, Shelley S; Thompson, Nicola D

See, Isaac; Soe, Minn M; Epstein, Lauren; Edwards, Jonathan R; Magill, Shelley S; Thompson, Nicola D.

Afiliación

See I; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA. Electronic address: gst8@cdc.gov.
Soe MM; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA.
Epstein L; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA.
Edwards JR; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA.
Magill SS; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA.
Thompson ND; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA.

Am J Infect Control ; 45(3): 321-323, 2017 Mar 01.

Article en En | MEDLINE | ID: mdl-27856070

Asunto(s)

Infecciones Relacionadas con Catéteres/epidemiología; Cateterismo Venoso Central/efectos adversos; Membrana Mucosa/lesiones; Sepsis/epidemiología; Sepsis/etiología; Humanos; Prevalencia

Palabras clave

Central lineassociated bloodstream infection; Oncology; Public reporting; Surveillance

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Cateterismo Venoso Central / Sepsis / Infecciones Relacionadas con Catéteres / Membrana Mucosa Tipo de estudio: Prevalence_studies / Risk_factors_studies Idioma: En Revista: Am J Infect Control Año: 2017 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google